- I-ELISA
Supplier Data
Indirect ELISA - Anti-SARS-CoV2 orf7b antibody [EPR26296-89] (AB322903)
Human orf7b concentration was interpolated from the orf7b standard curve. Samples were serially diluted and assessed by the Rabbit Monoclonal to SARS-CoV2 orf7b (ab322903). Orf7b immunogen and non-immunogen peptide, and Recombinant SARS-CoV-2 ORF7B Protein were assessed in duplicate (n=2). Data are represented as the mean and error bars represent standard deviation.
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com